Marshall Wace
SNDX icon

Marshall Wace’s Syndax Pharmaceuticals SNDX Stock Holding History

Marshall Wace’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-54,274
Closed -$1.27M – 3697
2026
Q1 		$1.27M Buy
+54,274
New +$1.18M ﹤0.01% 2017
2025
Q4 		– Sell
-233,973
Closed -$3.6M – 3444
2025
Q3 		$3.6M Buy
233,973
+1,850
+0.8% +$24.2K ﹤0.01% 1337
2025
Q2 		$2.17M Buy
+232,123
New +$2.55M ﹤0.01% 1515
2025
Q1 		– Sell
-12,624
Closed -$167K – 3060
2024
Q4 		$167K Sell
12,624
-977,280
-99% -$16.7M ﹤0.01% 2384
2024
Q3 		$19.1M Sell
989,904
-840,523
-46% -$17.4M 0.02% 525
2024
Q2 		$37.6M Sell
1,830,427
-201,632
-10% -$4.22M 0.05% 323
2024
Q1 		$48.4M Sell
2,032,059
-69,852
-3% -$1.56M 0.07% 264
2023
Q4 		$45.4M Buy
2,101,911
+1,497,949
+248% +$23M 0.08% 256
2023
Q3 		$8.77M Buy
+603,962
New +$11.4M 0.02% 684
2022
Q3 		– Sell
-11,637
Closed -$224K – 3757
2022
Q2 		$224K Sell
11,637
-97,981
-89% -$1.63M ﹤0.01% 3135
2022
Q1 		$1.91M Buy
109,618
+97,981
+842% +$1.65M ﹤0.01% 2097
2021
Q4 		$254K Hold
11,637
– – ﹤0.01% 3085
2021
Q3 		$222K Buy
+11,637
New +$194K ﹤0.01% 2771
2021
Q1 		– Sell
-191,788
Closed -$4.26M – 2823
2020
Q4 		$4.26M Buy
+191,788
New +$3.98M 0.02% 627
2020
Q2 		– Sell
-53,265
Closed -$584K – 1909
2020
Q1 		$584K Buy
+53,265
New +$500K 0.01% 944

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Marshall Wace's SNDX Position: Q2 2026 in Review

Marshall Wace sold out of Syndax Pharmaceuticals (SNDX) in Q2 2026, closing a stake of 54,274 shares — an estimated $1.27M sold.

Marshall Wace first reported a position in SNDX in Q1 2020 and held it in 15 quarters. The position peaked at $48.4M in Q1 2024. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Marshall Wace reported no remaining Syndax Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 54,274 Syndax Pharmaceuticals shares in Q2 2026, an estimated $1.27M.
  • Marshall Wace first reported a position in Syndax Pharmaceuticals in Q1 2020 and held it in 15 quarters.
  • Marshall Wace's Syndax Pharmaceuticals position peaked at $48.4M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.